Short description
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Description
Apexigen is a clinical-stage biopharmaceutical company developing antibody therapeutics for the treatment of cancer. It specializes in new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer.
Last funding
Nopepepe
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
San Carlos, California, United States, North America
Founded on
January 1, 2010
Closed on
August 23, 2023
Exited on
August 1, 2022
Went public on
August 1, 2022
Stock symbol
APGN
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccessforu, Noaccess, Uh Ohhhh, Noaccess, Noaccess, Absolutely Noaccess, Noway Youcantaccess, Cannot Access, Noaccess, Blurry Noaccess, Noaccess
Sign in for full access
Founders
Xiaodong Yang